Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/49972
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Perilli, Mariagrazia | en_US |
dc.contributor.author | Segatore, Bernardetta | en_US |
dc.contributor.author | Franceschini, Nicola | en_US |
dc.contributor.author | Gizzi, Giovanni | en_US |
dc.contributor.author | Mancinelli, Andrea | en_US |
dc.contributor.author | Caravelli, Berardo | en_US |
dc.contributor.author | Setacci, Domenico | en_US |
dc.contributor.author | Tavio-Perez, Maria Del Mar | en_US |
dc.contributor.author | Bianchi, Bruno | en_US |
dc.contributor.author | Amicosante, Gianfranco | en_US |
dc.date.accessioned | 2018-11-24T12:13:47Z | - |
dc.date.available | 2018-11-24T12:13:47Z | - |
dc.date.issued | 2001 | en_US |
dc.identifier.issn | 0924-8579 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/49972 | - |
dc.description.abstract | Ceftibuten is an oral third-generation cephalosporin active against a wide range of bacteria and shows an improved stability to hydrolysis by several beta -lactamases because of the carboxyethilidine moiety at position 7 of the beta -acyl side chain. The kinetic interactions between ceftibuten and active-site serine and metallo-beta -lactamases were investigated. The activity of several TEM-derived extended spectrum beta -lactamases (ES beta Ls) against ceftibuten, cefotaxime and ceftazidime was compared using K-m, K-cat and K-cat/K-m. Ceftibuten behaved as a poor substrate for class A and B beta -lactamases compared with cefotaxime. The chromosomal class C beta -lactamase from Enterobacter cloacae 908R gave a high k(cat) value (21 s(-1)), whereas there was poor activity with enzymes from Acinetobacter baumannii and Morganella morganii and ceftibuten. Ceftibuten resists hydrolysis in the presence of typical respiratory or urogenital-tract pathogens producing beta -lactamases. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | International Journal of Antimicrobial Agents | en_US |
dc.source | International Journal of Antimicrobial Agents[ISSN 0924-8579],v. 17(1), p. 45-50 (Enero 2001) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320103 Microbiología clínica | en_US |
dc.subject.other | Ceftibuten | en_US |
dc.subject.other | ß-Lactamases | en_US |
dc.subject.other | Affinity | en_US |
dc.subject.other | Catalytic efficiency | en_US |
dc.title | Ceftibuten stability to active-site serine and metallo-ß-lactamases | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/S0924-8579(00)00319-8 | en_US |
dc.identifier.scopus | 0035183274 | - |
dc.identifier.isi | 000166138400007 | - |
dc.contributor.authorscopusid | 7004624865 | - |
dc.contributor.authorscopusid | 6603452179 | - |
dc.contributor.authorscopusid | 7006270914 | - |
dc.contributor.authorscopusid | 15739386100 | - |
dc.contributor.authorscopusid | 15739718700 | - |
dc.contributor.authorscopusid | 6506024601 | - |
dc.contributor.authorscopusid | 6508070518 | - |
dc.contributor.authorscopusid | 6701659492 | - |
dc.contributor.authorscopusid | 7006898423 | - |
dc.contributor.authorscopusid | 7006729208 | - |
dc.description.lastpage | 50 | en_US |
dc.description.firstpage | 45 | en_US |
dc.relation.volume | 17 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 358961 | - |
dc.contributor.daisngid | 960054 | - |
dc.contributor.daisngid | 651911 | - |
dc.contributor.daisngid | 6630463 | - |
dc.contributor.daisngid | 7968336 | - |
dc.contributor.daisngid | 7614424 | - |
dc.contributor.daisngid | 2559602 | - |
dc.contributor.daisngid | 25688669 | - |
dc.contributor.daisngid | 11217610 | - |
dc.contributor.daisngid | 144499 | - |
dc.description.numberofpages | 6 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Perilli, M | - |
dc.contributor.wosstandard | WOS:Segatore, B | - |
dc.contributor.wosstandard | WOS:Franceschini, N | - |
dc.contributor.wosstandard | WOS:Gizzi, G | - |
dc.contributor.wosstandard | WOS:Mancinelli, A | - |
dc.contributor.wosstandard | WOS:Caravelli, B | - |
dc.contributor.wosstandard | WOS:Setacci, D | - |
dc.contributor.wosstandard | WOS:Tavio-Perez, MD | - |
dc.contributor.wosstandard | WOS:Bianchi, B | - |
dc.contributor.wosstandard | WOS:Amicosante, G | - |
dc.date.coverdate | Enero 2001 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 1,412 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR Investigación Básica y Aplicada en Ciencias de la Salud | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-1808-7461 | - |
crisitem.author.parentorg | Departamento de Ciencias Clínicas | - |
crisitem.author.fullName | Tavío Pérez, María Del Mar | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
6
checked on Nov 24, 2024
WEB OF SCIENCETM
Citations
6
checked on Nov 24, 2024
Page view(s)
83
checked on Nov 1, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.